Concord Wealth Partners Eli Lilly & CO Transaction History

Concord Wealth Partners

$591 Million
Q3 2024

A detailed history of Concord Wealth Partners transactions in Eli Lilly & CO stock. As of the latest transaction made, Concord Wealth Partners holds 5,067 shares of LLY stock, worth $4.05 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

5,067

Previous 4,651 8.94%

Holding current value

$4.05 Million

Previous $4.21 Million 6.63%

% of portfolio

0.76%

Previous 0.75%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $321,210 - $399,368	416 Added 8.94%	5,067 $4.49 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $14,497 - $18,180	20 Added 0.43%	4,651 $4.21 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $584,501 - $781,980	987 Added 27.09%	4,631 $3.6 Million
Q4 2023 Apr 30, 2024	BUY	$525.19 - $619.13 $322,991 - $380,764	615 Added 20.3%	3,644 $2.12 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $322,991 - $380,764	615 Added 20.3%	3,644 $2.12 Million
Q3 2023 Apr 30, 2024	SELL	$434.7 - $599.3 $267,340 - $368,569	-615 Reduced 16.88%	3,029 $1.63 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $173,880 - $239,719	-400 Reduced 11.67%	3,029 $1.63 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $344,075 - $460,069	981 Added 40.07%	3,429 $1.61 Million
Q1 2023 Apr 26, 2023	BUY	$310.63 - $364.82 $112,137 - $131,700	361 Added 17.3%	2,448 $840,000
Q4 2022 Jan 27, 2023	SELL	$321.55 - $374.67 $275,568 - $321,092	-857 Reduced 29.11%	2,087 $763,000
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $12,155 - $13,852	41 Added 1.41%	2,944 $952,000
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $215,179 - $252,652	772 Added 36.23%	2,903 $941,000
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $5,163 - $6,416	-22 Reduced 1.02%	2,131 $610,000
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $189,773 - $235,509	844 Added 64.48%	2,153 $595,000
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $244,203 - $300,526	-1,102 Reduced 45.71%	1,309 $302,000
Q2 2021 Jul 29, 2021	BUY	$180.55 - $233.54 $122,412 - $158,340	678 Added 39.12%	2,411 $553,000
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $174,507 - $225,908	1,062 Added 158.27%	1,733 $324,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $87,538 - $115,834	671 New	671 $113,000

Others Institutions Holding LLY

# of Institutions

4,016

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Account

Concord Wealth Partners Eli Lilly & CO Transaction History